Genocea Biosciences Inc (GNCA.OQ)

GNCA.OQ on NASDAQ Stock Exchange Global Market

7.53USD
19 Dec 2014
Price Change (% chg)

$-0.02 (-0.26%)
Prev Close
$7.55
Open
$7.53
Day's High
$7.97
Day's Low
$7.48
Volume
11,199
Avg. Vol
7,348
52-wk High
$23.88
52-wk Low
$7.20

GNCA.OQ

Chart for GNCA.OQ

About

Genocea Biosciences, Inc. is a United States-based clinical-stage company that develops T cell vaccines. The Company utilizes T cell immunity to develop the next generation of vaccines. It designs vaccines using ATLAS, its technology platform. It identifies T cell antigens to induce immune responses. Its pipeline of T cell... (more)

Overall

Beta: --
Market Cap (Mil.): $132.60
Shares Outstanding (Mil.): 17.61
Dividend: --
Yield (%): --

Financials

  GNCA.OQ Industry Sector
P/E (TTM): -- 37.83 38.47
EPS (TTM): -2.09 -- --
ROI: -101.01 18.99 18.25
ROE: -- 19.75 19.13
Search Stocks

Competitors

  Price Change
Novartis AG (NOVN.VX) CHF93.05 +0.95
Pfizer Inc. (PFE.N) $31.94 -0.03
Merck & Co., Inc. (MRK.N) $59.58 +0.60
Sanofi SA (SASY.PA) €75.38 -0.79
AstraZeneca plc (AZN.L) 4,565.00p -7.50
GlaxoSmithKline plc (GSK.L) 1,392.00p +13.50
Vical Incorporated (VICL.OQ) $1.07 --

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Ford Investor Services, Inc.
$12.00
Provider: Zacks Investment Research Inc.
$12.00
Provider: Zacks Investment Research Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks